Recent News
- Teijin Pharma Receives Additional Approval in Japan for Abaloparatide Acetate as Treatment for Osteoporosis
- Menarini Group’s Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced or Metastatic Breast Cancer
- Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc.
- Radius Health Announces Agreement to be Acquired by Gurnet Point Capital and Patient Square Capital